Centogene NV and ROPAD consortium publish data from a landmark study identifying genetic variants that may respond to ...
A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for ...
Yasir Gallero-Salas discusses quantifying alpha-synuclein spread and dopaminergic neuron loss in a model of Parkinson’s using ...
Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of ... Oct. 8, 2024 ...
Monday said Phase 3 TEMPO-2 study evaluating tavapadon in early Parkinson's disease met its primary goal. In the ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
When Denver artist Tim McKay was diagnosed with Parkinson’s disease last year, he made a quick decision: He would document ...
Funding has been made available which will enable new research to take place into a possible link between manganese exposure ...
Exidavnemab is a monoclonal antibody designed to eliminate aggregated clumps of the protein biomarker and slow progression of Parkinson's disease.
Wearable devices once seemed futuristic for Parkinson’s disease. Today, tools like activity trackers, tremor gloves, and ...